{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T17:43:01Z","timestamp":1783618981625,"version":"3.55.0"},"reference-count":70,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,12]],"date-time":"2021-08-12T00:00:00Z","timestamp":1628726400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.biopha.2021.112047","type":"journal-article","created":{"date-parts":[[2021,8,21]],"date-time":"2021-08-21T11:37:53Z","timestamp":1629545873000},"page":"112047","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["A recombinant selective drug-resistant M. bovis BCG enhances the bactericidal activity of a second-line anti-tuberculosis regimen"],"prefix":"10.1016","volume":"142","author":[{"given":"Gift","family":"Chiwala","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julius N.","family":"Mugweru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bangxing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahzad Akbar","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petuel Ndip Ndip","family":"Bate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Buhari","family":"Yusuf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.M. Adnan","family":"Hameed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cuiting","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaoju","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinxing","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shouyong","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianxiong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nanshan","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianyu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2021.112047_bib1","unstructured":"World Health Organization, Global Tuberculosis Report 2020, World Health Organization,Geneva, 2020."},{"issue":"11","key":"10.1016\/j.biopha.2021.112047_bib2","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1056\/NEJMra0908076","article-title":"MDR tuberculosis \u2013 critical steps for prevention and control","volume":"363","author":"Nathanson","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.biopha.2021.112047_bib3","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.coph.2018.05.013","article-title":"Drug-resistant tuberculosis: challenges and opportunities for diagnosis and treatment","volume":"42","author":"Koch","year":"2018","journal-title":"Curr. Opin. Pharmacol."},{"issue":"5","key":"10.1016\/j.biopha.2021.112047_bib4","doi-asserted-by":"crossref","first-page":"812","DOI":"10.3201\/eid2005.131037","article-title":"Treatment practices, outcomes, and costs of multidrug-resistant and extensively drug-resistant tuberculosis, United States, 2005\u20132007","volume":"20","author":"Marks","year":"2014","journal-title":"Emerg. Infect. Dis."},{"issue":"1579","key":"10.1016\/j.biopha.2021.112047_bib5","doi-asserted-by":"crossref","first-page":"2782","DOI":"10.1098\/rstb.2011.0097","article-title":"Tuberculosis vaccines: beyond bacille Calmette-Guerin","volume":"366","author":"McShane","year":"2011","journal-title":"Philos. Trans. R. Soc. Lond. B Biol. Sci."},{"issue":"1","key":"10.1016\/j.biopha.2021.112047_bib6","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1111\/imr.12255","article-title":"New tricks for old dogs: countering antibiotic resistance in tuberculosis with host-directed therapeutics","volume":"264","author":"Hawn","year":"2015","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.biopha.2021.112047_bib7","first-page":"37","article-title":"Immunotherapy for tuberculosis: future prospects","volume":"5","author":"Abate","year":"2016","journal-title":"ImmunoTargets Ther."},{"issue":"2","key":"10.1016\/j.biopha.2021.112047_bib8","doi-asserted-by":"crossref","DOI":"10.1128\/CVI.00439-16","article-title":"Safety and immunogenicity of the recombinant Mycobacterium bovis BCG vaccine VPM1002 in HIV-unexposed newborn infants in South Africa","volume":"24","author":"Loxton","year":"2017","journal-title":"Clin. Vaccine Immunol."},{"issue":"9","key":"10.1016\/j.biopha.2021.112047_bib9","doi-asserted-by":"crossref","first-page":"23826","DOI":"10.1371\/journal.pone.0023826","article-title":"Mycobacterium vaccae as adjuvant therapy to anti-tuberculosis chemotherapy in never-treated tuberculosis patients: a meta-analysis","volume":"6","author":"Yang","year":"2011","journal-title":"PLOS One"},{"key":"10.1016\/j.biopha.2021.112047_bib10","doi-asserted-by":"crossref","unstructured":"World Health Organization, BCG Vaccine: WHO Position Paper, February 2018 \u2013 Recommendations, Vaccine, 36(24), 2018, pp. 3408\u20133410.","DOI":"10.1016\/j.vaccine.2018.03.009"},{"issue":"9517","key":"10.1016\/j.biopha.2021.112047_bib11","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/S0140-6736(06)68507-3","article-title":"Effect of BCG vaccination on childhood tuberculous meningitis and miliary tuberculosis worldwide: a meta-analysis and assessment of cost-effectiveness","volume":"367","author":"Trunz","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.biopha.2021.112047_bib12","doi-asserted-by":"crossref","first-page":"5974","DOI":"10.1136\/bmj.d5974","article-title":"How does the level of BCG vaccine protection against tuberculosis fall over time?","volume":"343","author":"Rodrigues","year":"2011","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.biopha.2021.112047_bib13","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1128\/AAC.01302-08","article-title":"Susceptibility of Mycobacterium bovis BCG vaccine strains to antituberculous antibiotics","volume":"53","author":"Ritz","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.biopha.2021.112047_bib14","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.micpath.2017.08.040","article-title":"Antigen 85 complex as a powerful Mycobacterium tuberculosis immunogene: biology, immune-pathogenicity, applications in diagnosis, and vaccine design","volume":"112","author":"Karbalaei Zadeh Babaki","year":"2017","journal-title":"Microb. Pathog."},{"issue":"2","key":"10.1016\/j.biopha.2021.112047_bib15","doi-asserted-by":"crossref","first-page":"e00611","DOI":"10.1128\/mBio.00611-19","article-title":"Dynamics of Mycobacterium tuberculosis Ag85B revealed by a sensitive enzyme-linked immunosorbent assay","volume":"10","author":"Ernst","year":"2019","journal-title":"mBio"},{"issue":"8","key":"10.1016\/j.biopha.2021.112047_bib16","doi-asserted-by":"crossref","DOI":"10.1128\/IAI.00131-17","article-title":"The Mycobacterium tuberculosis MmpL11 cell wall lipid transporter is important for biofilm formation, intracellular growth, and nonreplicating persistence","volume":"85","author":"Wright","year":"2017","journal-title":"Infect. Immun."},{"issue":"9","key":"10.1016\/j.biopha.2021.112047_bib17","doi-asserted-by":"crossref","first-page":"5305","DOI":"10.1128\/IAI.69.9.5305-5312.2001","article-title":"Role of trehalose dimycolate in recruitment of cells and modulation of production of cytokines and NO in tuberculosis","volume":"69","author":"Lima","year":"2001","journal-title":"Infect. Immun."},{"issue":"8","key":"10.1016\/j.biopha.2021.112047_bib18","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a021113","article-title":"The mycobacterial cell wall\u2014peptidoglycan and arabinogalactan","volume":"5","author":"Alderwick","year":"2015","journal-title":"Cold Spring Harb. Perspect. Med."},{"issue":"3","key":"10.1016\/j.biopha.2021.112047_bib19","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1111\/j.1365-3083.2012.02726.x","article-title":"Novel recombinant BCG coexpressing Ag85B, ESAT-6 and Rv2608 elicits significantly enhanced cellular immune and antibody responses in C57BL\/6 mice","volume":"76","author":"Lu","year":"2012","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.biopha.2021.112047_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4137\/JCD.S2822","article-title":"Interferon-\u03b3 regulates the death of M. tuberculosis-infected macrophages","volume":"3","author":"Lee","year":"2010","journal-title":"J. Cell Death"},{"issue":"5","key":"10.1016\/j.biopha.2021.112047_bib21","doi-asserted-by":"crossref","first-page":"19105","DOI":"10.1371\/journal.pone.0019105","article-title":"Interferon gamma activated macrophages kill mycobacteria by nitric oxide induced apoptosis","volume":"6","author":"Herbst","year":"2011","journal-title":"PLOS One"},{"issue":"3","key":"10.1016\/j.biopha.2021.112047_bib22","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1046\/j.1365-2958.2003.03474.x","article-title":"Rv3133c\/dosR is a transcription factor that mediates the hypoxic response of Mycobacterium tuberculosis","volume":"48","author":"Park","year":"2003","journal-title":"Mol. Microbiol."},{"issue":"26","key":"10.1016\/j.biopha.2021.112047_bib23","doi-asserted-by":"crossref","first-page":"18032","DOI":"10.1074\/jbc.M802274200","article-title":"Heme oxygenase-1-derived carbon monoxide induces the Mycobacterium tuberculosis dormancy regulon","volume":"283","author":"Kumar","year":"2008","journal-title":"J. Biol. Chem."},{"issue":"15","key":"10.1016\/j.biopha.2021.112047_bib24","doi-asserted-by":"crossref","first-page":"4484","DOI":"10.1128\/jb.178.15.4484-4492.1996","article-title":"Stationary phase-associated protein expression in Mycobacterium tuberculosis: function of the mycobacterial alpha-crystallin homolog","volume":"178","author":"Yuan","year":"1996","journal-title":"J. Bacteriol."},{"issue":"152","key":"10.1016\/j.biopha.2021.112047_bib25","first-page":"152","article-title":"Recombinant BCG: innovations on an old vaccine. Scope of BCG strains and strategies to improve long-lasting memory","volume":"5","author":"da Costa","year":"2014","journal-title":"Front. Immunol."},{"issue":"8","key":"10.1016\/j.biopha.2021.112047_bib26","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1016\/j.micinf.2006.03.018","article-title":"Human T-cell responses to 25 novel antigens encoded by genes of the dormancy regulon of Mycobacterium tuberculosis","volume":"8","author":"Leyten","year":"2006","journal-title":"Microbes Infect."},{"key":"10.1016\/j.biopha.2021.112047_bib27","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1755-8794-1-18","article-title":"Whole genome identification of Mycobacterium tuberculosis vaccine candidates by comprehensive data mining and bioinformatic analyses","volume":"1","author":"Zvi","year":"2008","journal-title":"BMC Med. Genom."},{"issue":"1","key":"10.1016\/j.biopha.2021.112047_bib28","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1183\/09031936.00140009","article-title":"Response to Rv2628 latency antigen associates with cured tuberculosis and remote infection","volume":"36","author":"Goletti","year":"2010","journal-title":"Eur. Respir. J."},{"issue":"11","key":"10.1016\/j.biopha.2021.112047_bib29","doi-asserted-by":"crossref","first-page":"27539","DOI":"10.1371\/journal.pone.0027539","article-title":"Higher frequency of T-cell response to M. tuberculosis latency antigen Rv2628 at the site of active tuberculosis disease than in peripheral blood","volume":"6","author":"Chiacchio","year":"2011","journal-title":"PLOS One"},{"issue":"2","key":"10.1016\/j.biopha.2021.112047_bib30","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1128\/IAI.01137-06","article-title":"Immunogenicity of eight dormancy regulon-encoded proteins of Mycobacterium tuberculosis in DNA-vaccinated and tuberculosis-infected mice","volume":"75","author":"Roupie","year":"2007","journal-title":"Infect. Immun."},{"key":"10.1016\/j.biopha.2021.112047_bib31","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.tube.2017.10.010","article-title":"IgG subclasses\u2019 response to a set of mycobacterial antigens in different stages of Mycobacterium tuberculosis infection","volume":"108","author":"de Araujo","year":"2018","journal-title":"Tuberculosis"},{"key":"10.1016\/j.biopha.2021.112047_bib32","doi-asserted-by":"crossref","first-page":"332","DOI":"10.3389\/fmicb.2020.00332","article-title":"BCG as a case study for precision vaccine development: lessons from vaccine heterogeneity, trained immunity, and immune ontogeny","volume":"11","author":"Angelidou","year":"2020","journal-title":"Front. Microbiol."},{"issue":"11","key":"10.1016\/j.biopha.2021.112047_bib33","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1164\/rccm.200905-0795OC","article-title":"Short-course therapy with daily rifapentine in a murine model of latent tuberculosis infection","volume":"180","author":"Zhang","year":"2009","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"5","key":"10.1016\/j.biopha.2021.112047_bib34","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1128\/AAC.00110-08","article-title":"Pyrazinamide resistance and pncA gene mutations in Mycobacterium tuberculosis","volume":"52","author":"Jur\u00e9en","year":"2008","journal-title":"Antimicrob. Agents Chemother."},{"issue":"9","key":"10.1016\/j.biopha.2021.112047_bib35","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.4014\/jmb.1503.03053","article-title":"Role of folP1 and folP2 genes in the action of sulfamethoxazole and trimethoprim against mycobacteria","volume":"25","author":"Liu","year":"2015","journal-title":"J. Microbiol. Biotechnol."},{"issue":"3","key":"10.1016\/j.biopha.2021.112047_bib36","article-title":"Engineering more stable, selectable marker-free autoluminescent mycobacteria by one step","volume":"10","author":"Yang","year":"2015","journal-title":"PLOS One"},{"issue":"1","key":"10.1016\/j.biopha.2021.112047_bib37","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1093\/nar\/gnh005","article-title":"Method to integrate multiple plasmids into the mycobacterial chromosome","volume":"32","author":"Saviola","year":"2004","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.biopha.2021.112047_bib38","series-title":"Performance standards for antimicrobial susceptibility testing","year":"2017"},{"issue":"5","key":"10.1016\/j.biopha.2021.112047_bib39","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1164\/ajrccm\/140.5.1189","article-title":"Experimental short-course preventive therapy of tuberculosis with rifampin and pyrazinamide","volume":"140","author":"Lecoeur","year":"1989","journal-title":"Am. Rev. Respir. Dis."},{"key":"10.1016\/j.biopha.2021.112047_bib40","doi-asserted-by":"crossref","unstructured":"TB Alliance, Cycloserine, Tuberculosis, 88(2), 2008, pp. 100\u2013101.","DOI":"10.1016\/S1472-9792(08)70007-6"},{"issue":"1","key":"10.1016\/j.biopha.2021.112047_bib41","doi-asserted-by":"crossref","first-page":"29774","DOI":"10.1371\/journal.pone.0029774","article-title":"Autoluminescent Mycobacterium tuberculosis for rapid, real-time, non-invasive assessment of drug and vaccine efficacy","volume":"7","author":"Zhang","year":"2012","journal-title":"PLOS One"},{"issue":"2","key":"10.1016\/j.biopha.2021.112047_bib42","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1038\/mt.2015.216","article-title":"Variable virulence and efficacy of BCG vaccine strains in mice and correlation with genome polymorphisms","volume":"24","author":"Zhang","year":"2016","journal-title":"Mol. Ther."},{"key":"10.1016\/j.biopha.2021.112047_bib43","doi-asserted-by":"crossref","first-page":"29076","DOI":"10.1038\/srep29076","article-title":"Loss of lipid virulence factors reduces the efficacy of the BCG vaccine","volume":"6","author":"Tran","year":"2016","journal-title":"Sci. Rep."},{"issue":"5","key":"10.1016\/j.biopha.2021.112047_bib44","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1093\/infdis\/jiv503","article-title":"Pulmonary but not subcutaneous delivery of BCG vaccine confers protection to tuberculosis-susceptible mice by an interleukin 17\u2013dependent mechanism","volume":"213","author":"Aguilo","year":"2015","journal-title":"J. Infect. Dis."},{"issue":"7","key":"10.1016\/j.biopha.2021.112047_bib45","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1080\/21645515.2015.1042193","article-title":"Effects of the fusion design and immunization route on the immunogenicity of Ag85A-Mtb32 in adenoviral vectored tuberculosis vaccine","volume":"11","author":"Zhang","year":"2015","journal-title":"Hum. Vaccines Immunother."},{"issue":"4","key":"10.1016\/j.biopha.2021.112047_bib46","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.jmii.2012.06.008","article-title":"Resistance profiles and rpoB gene mutations of Mycobacterium tuberculosis isolates in Taiwan","volume":"46","author":"Lin","year":"2013","journal-title":"J. Microbiol. Immunol. Infect."},{"issue":"4","key":"10.1016\/j.biopha.2021.112047_bib47","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1128\/jcm.32.4.1095-1098.1994","article-title":"Characterization by automated DNA sequencing of mutations in the gene (rpoB) encoding the RNA polymerase beta subunit in rifampin-resistant Mycobacterium tuberculosis strains from New York City and Texas","volume":"32","author":"Kapur","year":"1994","journal-title":"J. Clin. Microbiol."},{"issue":"3","key":"10.1016\/j.biopha.2021.112047_bib48","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1093\/trstmh\/trw006","article-title":"Drug-resistant TB: deadly, costly and in need of a vaccine","volume":"110","author":"Manjelievskaia","year":"2016","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"issue":"11","key":"10.1016\/j.biopha.2021.112047_bib49","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.1016\/j.vaccine.2009.12.083","article-title":"The second Geneva consensus: recommendations for novel live TB vaccines","volume":"28","author":"Walker","year":"2010","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.biopha.2021.112047_bib50","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.ijpharm.2011.09.020","article-title":"Evaluation of the immunogenicity and in vivo toxicity of the antimicrobial peptide P34","volume":"421","author":"de Almeida Vaucher","year":"2011","journal-title":"Int. J. Pharm."},{"issue":"16","key":"10.1016\/j.biopha.2021.112047_bib51","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1128\/JB.00275-16","article-title":"Multifaceted Interfaces of bacterial competition","volume":"198","author":"Stubbendieck","year":"2016","journal-title":"J. Bacteriol."},{"issue":"4","key":"10.1016\/j.biopha.2021.112047_bib52","first-page":"260","article-title":"In vitro anti-bacterial and anti-adherence effects of Lactobacillus delbrueckii subsp bulgaricus on Escherichia coli","volume":"8","author":"Abedi","year":"2013","journal-title":"Res. Pharm. Sci."},{"issue":"9","key":"10.1016\/j.biopha.2021.112047_bib53","doi-asserted-by":"crossref","first-page":"3205","DOI":"10.1128\/iai.59.9.3205-3212.1991","article-title":"The genes coding for the antigen 85 complexes of Mycobacterium tuberculosis and Mycobacterium bovis BCG are members of a gene family: cloning, sequence determination, and genomic organization of the gene coding for antigen 85-C of M. tuberculosis","volume":"59","author":"Content","year":"1991","journal-title":"Infect. Immun."},{"issue":"5","key":"10.1016\/j.biopha.2021.112047_bib54","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1164\/rccm.201304-0753OC","article-title":"Assessment of clofazimine activity in a second-line regimen for tuberculosis in mice","volume":"188","author":"Grosset","year":"2013","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.biopha.2021.112047_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.110782","article-title":"TB47 and clofazimine form a highly synergistic sterilizing block in a second-line regimen for tuberculosis in mice","volume":"131","author":"Yu","year":"2020","journal-title":"Biomed. Pharmacother."},{"issue":"3","key":"10.1016\/j.biopha.2021.112047_bib56","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1371\/journal.pmed.0040120","article-title":"Why is long-term therapy required to cure tuberculosis?","volume":"4","author":"Connolly","year":"2007","journal-title":"PLOS Med."},{"issue":"8","key":"10.1016\/j.biopha.2021.112047_bib57","doi-asserted-by":"crossref","first-page":"1041.e1","DOI":"10.1016\/j.cmi.2018.12.008","article-title":"Detection of novel mutations associated with independent resistance and cross-resistance to isoniazid and prothionamide in Mycobacterium tuberculosis clinical isolates","volume":"25","author":"Islam","year":"2019","journal-title":"Clin. Microbiol. Infect."},{"issue":"2","key":"10.1016\/j.biopha.2021.112047_bib58","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1089\/hgtb.2018.211","article-title":"Immunogenicity and therapeutic effects of latency-associated genes in a Mycobacterium tuberculosis reactivation mouse model","volume":"30","author":"Liang","year":"2019","journal-title":"Hum. Gene Ther. Methods"},{"issue":"11","key":"10.1016\/j.biopha.2021.112047_bib59","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0112848","article-title":"A new recombinant BCG vaccine induces specific Th17 and Th1 effector cells with higher protective efficacy against tuberculosis","volume":"9","author":"da Costa","year":"2014","journal-title":"PLOS One"},{"issue":"1","key":"10.1016\/j.biopha.2021.112047_bib60","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1183\/09031936.00113413","article-title":"Bacille Calmette\u2013Gu\u00e9rin vaccination: the current situation in Europe","volume":"43","author":"Dara","year":"2014","journal-title":"Eur. Respir. J."},{"issue":"3469","key":"10.1016\/j.biopha.2021.112047_bib61","article-title":"Sex differences in immunity: implications for the development of novel vaccines against emerging pathogens","volume":"11","author":"Fathi","year":"2020","journal-title":"Front. Immunol."},{"issue":"9","key":"10.1016\/j.biopha.2021.112047_bib62","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1164\/rccm.201012-1949OC","article-title":"Treatment of tuberculosis with rifamycin-containing regimens in immune-deficient mice","volume":"183","author":"Zhang","year":"2011","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.biopha.2021.112047_bib63","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1146\/annurev.immunol.021908.132703","article-title":"Cell-mediated immune responses in tuberculosis","volume":"27","author":"Cooper","year":"2009","journal-title":"Annu. Rev. Immunol."},{"issue":"3","key":"10.1016\/j.biopha.2021.112047_bib64","doi-asserted-by":"crossref","DOI":"10.1183\/23120541.00026-2017","article-title":"Chronic airflow obstruction after successful treatment of multidrug-resistant tuberculosis","volume":"3","author":"Byrne","year":"2017","journal-title":"ERJ Open Res."},{"issue":"1","key":"10.1016\/j.biopha.2021.112047_bib65","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/imr.12671","article-title":"Dynamic balance of pro- and anti-inflammatory signals controls disease and limits pathology","volume":"285","author":"Cicchese","year":"2018","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.biopha.2021.112047_bib66","article-title":"Pathogenesis of human pulmonary tuberculosis","author":"Dannenberg","year":"2006","journal-title":"Am. Soc. Microbiol."},{"issue":"6","key":"10.1016\/j.biopha.2021.112047_bib67","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.tube.2011.03.007","article-title":"Pathology of post primary tuberculosis of the lung: an illustrated critical review","volume":"91","author":"Hunter","year":"2011","journal-title":"Tuberculosis"},{"issue":"11","key":"10.1016\/j.biopha.2021.112047_bib68","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1000204","article-title":"Foamy macrophages from tuberculous patients\u2019 granulomas constitute a nutrient-rich reservoir for M. tuberculosis persistence","volume":"4","author":"Peyron","year":"2008","journal-title":"PLOS Pathog."},{"issue":"9","key":"10.1016\/j.biopha.2021.112047_bib69","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1038\/ni.1781","article-title":"Foamy macrophages and the progression of the human tuberculosis granuloma","volume":"10","author":"Russell","year":"2009","journal-title":"Nat. Immunol."},{"issue":"2","key":"10.1016\/j.biopha.2021.112047_bib70","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.vaccine.2019.10.072","article-title":"Preferred product characteristics for therapeutic vaccines to improve tuberculosis treatment outcomes: key considerations from World Health Organization consultations","volume":"38","author":"Vekemans","year":"2020","journal-title":"Vaccine"}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332221008301?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332221008301?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T12:40:44Z","timestamp":1760100044000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332221008301"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":70,"alternative-id":["S0753332221008301"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2021.112047","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2021.03.04.434024","asserted-by":"object"}]},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A recombinant selective drug-resistant M. bovis BCG enhances the bactericidal activity of a second-line anti-tuberculosis regimen","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2021.112047","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"112047"}}